BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 18023220)

  • 1. Pocket extraction on proteins via the Voronoi diagram of spheres.
    Kim D; Cho CH; Cho Y; Ryu J; Bhak J; Kim DS
    J Mol Graph Model; 2008 Apr; 26(7):1104-12. PubMed ID: 18023220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The automatic search for ligand binding sites in proteins of known three-dimensional structure using only geometric criteria.
    Peters KP; Fauck J; Frömmel C
    J Mol Biol; 1996 Feb; 256(1):201-13. PubMed ID: 8609611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physics-based methods for studying protein-ligand interactions.
    Huang N; Jacobson MP
    Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive identification of "druggable" protein ligand binding sites.
    An J; Totrov M; Abagyan R
    Genome Inform; 2004; 15(2):31-41. PubMed ID: 15706489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of pockets on protein surfaces using small and large probe spheres to find putative ligand binding sites.
    Kawabata T; Go N
    Proteins; 2007 Aug; 68(2):516-29. PubMed ID: 17444522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular optimization using computational multi-objective methods.
    Nicolaou CA; Brown N; Pattichis CS
    Curr Opin Drug Discov Devel; 2007 May; 10(3):316-24. PubMed ID: 17554858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Form follows function: shape analysis of protein cavities for receptor-based drug design.
    Weisel M; Proschak E; Kriegl JM; Schneider G
    Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BetaDock: shape-priority docking method based on beta-complex.
    Kim DS; Kim CM; Won CI; Kim JK; Ryu J; Cho Y; Lee C; Bhak J
    J Biomol Struct Dyn; 2011 Aug; 29(1):219-42. PubMed ID: 21696235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.
    Fauman EB; Rai BK; Huang ES
    Curr Opin Chem Biol; 2011 Aug; 15(4):463-8. PubMed ID: 21704549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-like density: a method of quantifying the "bindability" of a protein target based on a very large set of pockets and drug-like ligands from the Protein Data Bank.
    Sheridan RP; Maiorov VN; Holloway MK; Cornell WD; Gao YD
    J Chem Inf Model; 2010 Nov; 50(11):2029-40. PubMed ID: 20977231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large-scale computational approach to drug repositioning.
    Li YY; An J; Jones SJ
    Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relaxed complex method: Accommodating receptor flexibility for drug design with an improved scoring scheme.
    Lin JH; Perryman AL; Schames JR; McCammon JA
    Biopolymers; 2003 Jan; 68(1):47-62. PubMed ID: 12579579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of AMANDA, a new algorithm for selecting highly relevant regions in Molecular Interaction Fields.
    Durán A; Martínez GC; Pastor M
    J Chem Inf Model; 2008 Sep; 48(9):1813-23. PubMed ID: 18693718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.